Amphastar - AMPH Operatsion marja

Amphastar (AMPH) kompaniyasining rasmiy ramzlari

Amphastar Pharmaceuticals (AMPH) ichki tadqiqotlarni yetuk aktivlarning maqsadli sotib olishlari bilan to'ldiruvchi gibrid modelni ishlab chiqmoqda. Operatsion foyda marjasi tarixi barqaror trayektoriya ko'rsatmoqda, bunda ko'rsatkich 18.70 darajasida qat'iy belgilangan. Yuqori texnologik to'siqlar kutilgan pul oqimini ta'minlaydi, shpital va dorixonalarga mo'ljallangan murakkab in'ektsion dori vositalari ishlab chiqarish esa bozor risklarini samarali diversifikatsiya qiladi.

Amphastar Pharmaceuticals Inc (AMPH): Operatsion faoliyat rentabelligi 04.07.2022dan 19.11.2026gacha

amphastar.com (AMPH) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:Amphastar
Amphastar Pharmaceuticals tayyor mahsulotlari

Amphastar Pharmaceuticals (AMPH) kompaniyasining inyeksion ishlab chiqarish quvvatlaridan to'liq foydalanish xarajatlarni boshqarish samaradorligiga bevosita ta'sir qiladi. Ushbu ko'rsatkich operatsion foydaning tushumga nisbati sifatida hisoblanadi va qarz yuklamasi hamda soliqlarning ta'sirini ajratib ko'rsatadi. Bu ishlab chiqarish jarayonlarining haqiqiy daromadliligini va operatsion boshqaruv sifatini baholash imkonini beradi. Ushbu ko'rsatkichning barqarorligi biznesning joriy sikldagi chidamliligini tasdiqlaydi. EBIT marjasi dinamikasi investorlarga daromadlilikning cho'qqisiga yetish xavfini o'z vaqtida aniqlashga yordam beradi.

Amphastar Pharmaceuticals raqobatchilari tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.